1
项与 Human Placental Derived Stem Cell(New York Medical College) 相关的临床试验A Single-Arm Study to Assess the Safety of Transplantation With Human Placental-Derived Stem-Cells Combined With Unrelated and Related Cord Blood in Subjects With Certain Malignant Hematologic Diseases and Non-Malignant Disorders
The purpose of this clinical trial is to investigate the safety of human placental-derived stem cells (HPDSC) given in conjunction with umbilical cord blood (UCB) stem cells in patients with various malignant or nonmalignant disorders who require a stem cell transplant. Patients will get either full dose (high-intensity) or lower dose (low intensity) chemo- and immunotherapy followed by a stem cell transplantation with UCB and HPDSC.
100 项与 Human Placental Derived Stem Cell(New York Medical College) 相关的临床结果
100 项与 Human Placental Derived Stem Cell(New York Medical College) 相关的转化医学
100 项与 Human Placental Derived Stem Cell(New York Medical College) 相关的专利(医药)
100 项与 Human Placental Derived Stem Cell(New York Medical College) 相关的药物交易